|
Volumn 110, Issue 4, 2000, Pages 884-886
|
Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis
|
Author keywords
Chemotherapy; Clonality; HUMARA; Long term remission; Myelodysplastic syndrome
|
Indexed keywords
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
MITOXANTRONE;
TIOGUANINE;
ADULT;
AGED;
ARTICLE;
CELL CLONE;
CLINICAL ARTICLE;
DISEASE ASSOCIATION;
FEMALE;
FOLLOW UP;
GRANULOCYTE;
HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MYELODYSPLASTIC SYNDROME;
PRIORITY JOURNAL;
REMISSION;
T LYMPHOCYTE ACTIVATION;
X CHROMOSOME INACTIVATION;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DOSAGE COMPENSATION, GENETIC;
FEMALE;
FOLLOW-UP STUDIES;
HEMATOPOIESIS;
HUMANS;
IDARUBICIN;
MIDDLE AGED;
MITOXANTRONE;
MYELODYSPLASTIC SYNDROMES;
RETROSPECTIVE STUDIES;
THIOGUANINE;
TIME FACTORS;
|
EID: 0033755020
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2000.02302.x Document Type: Article |
Times cited : (23)
|
References (11)
|